Israel in Talks With Russia for Sputnik V COVID-19 Vaccine
Error: Contact form not found.
by Reuters and Algemeiner Staff

A nurse prepares Russia’s ‘Sputnik-V’ vaccine against the coronavirus disease (COVID-19), for inoculation in a post-registration trials stage, at a clinic in Moscow, Russia, Sept. 17, 2020. Photo: Reuters / Tatyana Makeyeva.
Israel cast a wider net on Monday in its quest to secure a vaccine for COVID-19, approaching Russia to discuss buying its Sputnik V vaccine.
“About an hour ago I spoke with Russian President Vladmir Putin regarding the possibility of purchasing an option on the vaccine Sputnik-V,” Israeli Prime Minister Benjamin Netanyahu told reporters. “We will discuss this in the coming days.”
Israel was early to sign with Moderna for its potential vaccine, reaching an agreement in June. Last week, it signed another deal with Pfizer. Both companies have reported encouraging trial results.
Israel is also developing its own vaccine that, if successful, could be market-ready by the end of the summer.
“My goal is to bring as many vaccines from as many sources to as many citizens, as quickly as possible,” Netanyahu said.
UNICEF Report Dispels Gaza Famine Narrative, Enclave Less Malnourished Than Finland
Saudi Arabia, Turkey, Pakistan Pledge Mutual Defence as Middle East Turmoil Escalates
Israeli Foreign Minister Meets Colombia’s New Leadership as Both Countries Move to Rebuild Strategic Ties
Israeli Mother and Daughter Brutally Assaulted in Thailand in Suspected Antisemitic Attack
Ye Moves Forward With Portugal Concert Despite Calls for Cancellation From Israeli Ambassador
We Must Build the New Generation of Jewish Activists
This War Changed India’s Future — and Its Relations with Israel and the United States
I’m Israeli; Are My Household Appliances Spying for Iran?
How the Media Helps Spread Libels About Israel’s Historical Sites
Italian Jewish Teenagers Targeted in Antisemitic Attack at Bulgarian Summer Camp Amid Escalating Hostility Across Europe









